Scientists have discovered that by knocking down a single gene, they can fix stress-induced infertility in rats.
Although stress has been linked to decreased sex drive, delayed pregnancy and an increase in miscarriages, this is the first time the molecular basis for the links has been explored.
Chances of Infertility in Men Who Use Sunscreen
Advanced Reproductive Care, Inc., the largest network of fertility specialists in the United States advice men to use sunscreen in moderation.
Advertisement
Daniela Kaufer from the University of California Berkeley said that remarkably, genetic silencing of a single chemical compound, a peptide called RFRP3, restores mating and pregnancy success to a rate indistinguishable from non-stress controls.
Stressed females were less motivated to mate, became pregnant less often and - in those that did copulate successfully - fewer live pups made it to term and were instead reabsorbed into the uterus. The findings show that the impact of stress lingers long after the stress has been removed. These marked effects were completely eliminated by knocking down RFRP3.
![Research Highlights New Angle on Infertility]( "Research Highlights New Angle on Infertility")
A single mutation in the beta-catenin gene can lead to infertility.
Lead author Anna Geraghty said that a strikingly high proportion of healthy women struggle with fertility and our findings provide a new focus for the clinical study of human reproductive health.
RFRP3 is the mammalian equivalent of a hormone first identified in Japanese quail and is made in the hypothalamus portion of the brain. One way it exerts its effect on females is by decreasing the normal surge in hormones that accompanies ovulation.
It may be directly regulated by the stress hormone corticosterone. However, even after recovery from stress, when corticosterone levels have returned to normal, RFRP3 was found to continue exerting its effect on reproduction.
The study is published in the open access journal eLife.
Source: ANI
Research Highlights New Angle on Infertility
A single mutation in the beta-catenin gene can lead to infertility.
Advertisement
Lead author Anna Geraghty said that a strikingly high proportion of healthy women struggle with fertility and our findings provide a new focus for the clinical study of human reproductive health.
RFRP3 is the mammalian equivalent of a hormone first identified in Japanese quail and is made in the hypothalamus portion of the brain. One way it exerts its effect on females is by decreasing the normal surge in hormones that accompanies ovulation.
It may be directly regulated by the stress hormone corticosterone. However, even after recovery from stress, when corticosterone levels have returned to normal, RFRP3 was found to continue exerting its effect on reproduction.
The study is published in the open access journal eLife.
Source: ANI
Kenya Dismisses Catholic Infertility Fears Over Tetanus Vaccine
Kenya on Friday said a tetanus vaccination campaign was entirely safe and would save children's lives, dismissing remarks by the country's Roman Catholic church it makes women infertile.
Advertisement
 New Insights into Male InfertilityMale infertility can be caused by diseases and other factors. 40% of infertility is caused due to male factors and additionally 40% is caused by female factors, says expert. | Advertisement
|
Advertisement
Recommended Reading
Latest Research News
The International Space Station will be used to carry out experiments seeking to improve understanding of incurable child brain tumors and the muscle aging process.
How many people in the UK have misophonia? In a representative sample study, most people had at least some irritation upon hearing trigger sounds.
Routine eye-checkups and mass screenings enable early diagnosis and treatment of glaucoma. Late-stage glaucoma diagnosis leads to blindness.
Brain plasticity following blindness leads to superior ability in sensing signals from the heart, which has implications for bodily awareness and emotional processing.
A group of scientists were awarded £1.3 million to create a new “point of care testing” kit that detects Alzheimer's disease biomarkers.